UBS Group AG - NEUROCRINE BIOSCIENCES INC ownership

NEUROCRINE BIOSCIENCES INC's ticker is and the CUSIP is 64125CAD1. A total of 39 filers reported holding NEUROCRINE BIOSCIENCES INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NEUROCRINE BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,484
+16.6%
1,0000.0%0.00%
Q2 2023$1,273
-5.1%
1,0000.0%0.00%
Q1 2023$1,342
-99.1%
1,0000.0%0.00%
Q4 2022$157,650
+5155.0%
1,000
-50.0%
0.00%
Q2 2022$3,000
+200.0%
2,000
+100.0%
0.00%
Q1 2019$1,000
-100.0%
1,000
-99.9%
0.00%
-100.0%
Q3 2018$2,647,0001,553,0000.00%
Other shareholders
NEUROCRINE BIOSCIENCES INC shareholders Q2 2022
NameSharesValueWeighting ↓
CSS LLC/IL 15,659,000$23,207,6871.52%
SONA ASSET MANAGEMENT (US) LLC 17,500,000$26,317,9521.09%
TENOR CAPITAL MANAGEMENT Co., L.P. 26,765,000$40,113,0990.86%
Warberg Asset Management LLC 1,271,000$1,885,8460.38%
SSI INVESTMENT MANAGEMENT LLC 2,296,000$3,406,1160.28%
Paloma Partners Management Co 3,125,000$4,694,5900.16%
FRANKLIN RESOURCES INC 54,750,000$81,769,1250.04%
Rock Springs Capital Management LP 1,000,000$1,497,9500.04%
LORD, ABBETT & CO. LLC 4,666,000$6,9220.03%
D. E. Shaw & Co., Inc. 14,351,000$21,373,1970.02%
View complete list of NEUROCRINE BIOSCIENCES INC shareholders